We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunoglobulin E Tests Not Always Reliable for Infants

By LabMedica International staff writers
Posted on 02 Jan 2012
Physicians are warned not to rely on allergen-specific immunoglobulin E (IgE) tests for pediatric allergies.

The mere detection of sensitization to an allergen on IgE tests is not always equivalent to a clinical diagnosis, cautioned a clinical report from the American Academy of Pediatrics (AAP).

The advisory from two allergists, Robert Wood of the Johns Hopkins Children's Center (Baltimore, MD, USA) and Scott Sicherer of Mt. More...
Sinai Hospital (New York, NY, USA), urges clinicians to use caution when ordering allergy tests and to avoid making a diagnosis based solely on test results.

Most allergies result in the production of IgE antibodies that are specific to that allergen. A report, published in the January 2012 issue of Pediatrics, offers aid to pediatricians in selecting the appropriate allergy tests, and interpreting the results in the context of a patient history and clinical presentation.

The detailed medical history and tests must be interpreted in the presence of a clinical presentation, the authors noted. For instance, a child who eats eggs without any symptoms does not need to undergo testing for an egg allergy. The same holds true for pollen testing when a child is not physically exposed to a certain pollen.

In vitro allergen-specific immunoglobulin E (sIgE) testing is widely available to physicians, but the report sets out several caveats that physicians need to keep in mind when using these tests and before embarking on immunotherapy.

Both serum sIgE tests and skin-prick tests have similar diagnostic properties with specific pros and cons. Skin-prick tests offer immediate results and are low cost, but they require the availability of rash-free skin.

Serologic tests are not affected by antihistamines or extensive dermatitis, but require a blood sample and cost more.

The report also includes guidance on specific allergies: e.g., for asthma the physician is advised to follow national guidelines and test for indoor allergens (dust mites, mold). There is no current evidence that testing for total IgE will identify specific food allergies. In addition IgE tests are not relevant for many drug reactions. The diagnostic value of serum tests is not well characterized for latex allergies. A localized reaction at an insect bite or sting site does not indicate a risk for anaphylaxis; testing is not warranted.

In vitro allergen-specific immunoglobulin E (sIgE) testing is widely available to physicians, but the report sets out several caveats that physicians need to keep in mind when using these tests and before embarking on immunotherapy.

Related Links:

Johns Hopkins Children's Center
Mt. Sinai Hospital



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.